Anindya Das

Anindya Das

Auto-generated profile, based on publicly available information

Anindya Das

Department of Psychiatry, AIIMS Rishikesh, Uttarakhand, India

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2012 in Critical Public Health
Verified
Journal Article
Closed access
ADAnindya Das
Anindya Das
MRMohan Rao
Mohan Rao
(2012). Universal mental health: re-evaluating the call for global mental health. Critical Public Health: Vol. 22, No. 4, pp. 383-389.

12 October 2009 in International Journal of Social Psychiatry
Verified
Journal Article
Closed access
PDF file
ADAnindya Das
Anindya Das
Farmers’ suicide in India is a cause of concern and government figures, though conservative, predict an impending epidemic. Various measures to curb this calamity are being made in a piecemeal manner. Considering it as an issue of social and mental health concern, this article attempts to evaluate the situation based on the tenet that health and illness are the result of a complex interplay between biological, psychological, social, environmental, economic and political factors. Thus in India the agrarian crisis, among other causes, has been largely debated as the major reason for the current state of farmers. It is important that (psychiatric) epidemiology and public mental health try to evolve mechanisms to understand and implement measures, and take this into consideration when attempting health promotion and prevention.

1 January 2018 in Lung India
Verified
Journal Article
Open access
PDF file
RDRuchi Dua
Ruchi Dua
ADAnindya Das
Anindya Das
AKAbhishek Kumar
Abhishek Kumar
SKSandeep Kumar
Sandeep Kumar
MMMayank Mishra
Mayank Mishra
KSKapil Sharma
Kapil Sharma
Background: Chronic obstructive pulmonary disease (COPD) is a disease with known systemic manifestations including psychiatric comorbidities most commonly being depression and/or anxiety. Studies regarding the association of these psychiatric comorbidities in terms of symptom scores, spirometric variables, and hospitalizations among patients of COPD are lacking, especially in India. Materials and Methods: One hundred and twenty-eight patients of COPD attending the Outpatient Department of AIIMS Rishikesh, and fulfilling inclusion criteria were screened by Hospital Anxiety and Depression Scale, and those who scored above the cutoff underwent psychiatric evaluation using the International Classification of Diseases, Tenth Edition Diagnostic Criteria for Research for confirmation of their diagnosis. All patients were then evaluated by physician-administered questionnaire for symptom scores by Modified Medical Research Council Scale (mMRC) for dyspnea, Hindi-validated Clinical COPD Questionnaire (CCQ), and for functional capacity by 6-min walk distance (6MWD) according to the American Thoracic Society Guidelines. All patients also underwent spirometric evaluation, and postbronchodilator forced expiratory volume in 1 s (FEV1), BODE index (body mass index [BMI], postbronchodilator FEV1, mMRC for dyspnea, 6MWD) and a history of hospitalization/exacerbations over the past 1 year was also obtained. Comparison of symptom scores, functional capacity in terms of 6MWD, history of exacerbations or hospitalizations over preceding 1 year and BODE index between patients of COPD with or without anxiety and/or depression was done. Results: COPD patients with comorbid anxiety and/or depression had higher dyspnea scores and CCQ scores though the proportion of current smokers, BMI, history of hospitalization over the past 1 year, FEV1, and BODE index was not statistically significant between the two groups. Conclusions: Depression is a common comorbidity and leads to higher symptom scores as well as poorer quality of life among COPD patients.

1 June 2007 in Journal of Clinical Psychopharmacology
Verified
Journal Article
Closed access
PDPushpal Desarkar
Pushpal Desarkar
ADAnindya Das
Anindya Das
SNS. Haque Nizamie
S. Haque Nizamie

1 January 2013 in Indian Journal of Psychological Medicine
Verified
Journal Article
Open access
PDF file
ADAnindya Das
Anindya Das
Background: Comorbidity in bipolar disorder (BP) is common, of which anxiety disorder (AD) comorbidity has received recent attention. The aim of the present study was to find the prevalence of (current and lifetime) ADs in BP I with recent episode mania, its effect on illness severity and its treatment implications. This is unlike the convention of associating ''anxiety'' with depression. Here, the hierarchical diagnostic criterion of the DSM IV-TR was suspended for heuristic purpose. Materials and Methods: Consecutively admitted 102 consenting in-patients of bipolar mania were evaluated on Young Mania Rating Scale, Brief Psychiatric Rating Scale, and Hamilton Rating Scale for Anxiety, at baseline and after 45 days. When the patient became cooperative, Schedule for Affective Disorders and Schizophrenia - the lifetime version interview AD section, was conducted. Protocol for management of current acute state was kept flexible and naturalistic. All treatment details, historical bipolar illness and socio-demographic variables were collected from case record file and unstructured interview with patient and caregiver. Results: High prevalence of lifetime (70.2 percent) and moderate levels of current (29.6 percent) comorbid ADs were found. Comorbid lifetime AD was associated with more severe BP course (more past depressive episodes ( P<0.001), less inter-episode recovery ( P<0.01), and poorer response to acute phase treatment). Comorbid AD group needed more number of mood stabilizers for acute management ( P<0.05). Conclusion: Findings illustrate the importance of this comorbidity having implications for psychiatric diagnostic systems.

1 March 2011 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
ADAnindya Das
Anindya Das